… Monoclonal antibodies (mAbs) targeting the spike protein of SARS-CoV-2 have been widely
used in the ongoing COVID-19 pandemic. In this paper, we review the properties of mAbs …

… Owing to their high specificity and reliability, monoclonal antibodies (mAbs) have emerged …
syndrome coronavirus 2 (SARS-CoV-2) and Ab drugs for use as COVID-19 therapeutic agents…

… Human monoclonal antibodies (mAbs) that neutralize Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2… and imdevimab) against SARS-CoV-2 was approved for passive …

… Numerous mAbs have been developed against SARS-CoV 2 and have proven … the
monoclonal antibodies currently authorized for the treatment of the coronavirus disease 19 (COVID-19…

… SARS-CoV-2 monoclonal antibodies and how might they be used in the future? At this time,
anti–SARS-CoV-2 monoclonal antibodies … patients with mild to moderate COVID-19. If, in the …

… report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell
… of a (human) monoclonal antibody that neutralizes SARS-CoV-2. 47D11 binds a conserved …

… antibodies against variant strains of SARS-CoV-2 1,2,3 , the in … activity of a panel of monoclonal
antibodies (mAbs), which … and Lilly, against SARS-CoV-2 variant viruses. Although some …

… of newly emerging SARS-CoV-2 variants, we suggest the importance of rapid evaluation
of the efficiency of therapeutic monoclonal antibodies against novel SARS-CoV-2 variants. …

… , the COVID-19 pandemic … monoclonal antibody (mAb) arena for COVID-19 has been
exploited through use of anti-inflammatory mAbs aimed at managing the cytokine storm, Citation2 …

… Monoclonal antibodies (mAbs) offer a treatment option for individuals with severe COVID-19 …
Given the importance of understanding the evolution of resistance to mAbs by SARS-CoV-2, …